Skip to main content
main-content

Type 2 diabetes


Browse the latest news, expert commentary, and educational content on type 2 diabetes.


Highlights

21-09-2021 | Hypoglycemia | View from the clinic | Article

Hypoglycemia in people taking alpha-glucosidase inhibitors

Sanjay Kalra explains how use of alpha-glucosidase inhibitors in people with type 2 diabetes can complicate the treatment of hypoglycemia.

20-09-2021 | Heart failure | News

Gestational diabetes may flag early HF risk

The presence of gestational diabetes mellitus may identify women at an increased risk for experiencing hospitalization for heart failure within the next few years, research suggests.

15-09-2021 | ESC 2021 | Conference coverage | Video

FIGARO: Where will finerenone fit into diabetic kidney disease treatment?

David Wheeler talks about the findings of the FIGARO trial, the use of finerenone in people with type 2 diabetes, and how this may fit with SGLT2 inhibitors.

Semaglutide for weight loss: The STEP and SELECT trials

Get the latest results and insights from the researchers.

More on type 2 diabetes

View from the clinic: Sanjay Kalra

Expert insights on identifying appropriate patient profiles when considering the use of medication combinations.

SGLT2 inhibitor use in type 2 diabetes management

Learn about prescribing these medications with guidance from the Improving Diabetes Steering Committee.

  • » A prescribing tool to inform prescribing decisions for SGLT2 inhibitors
  • » SGLT2 inhibitors: Key evidence and implications for clinical practice
  • » Translating SGLT2 inhibitor cardiovascular evidence into practice
  • » This content is intended only for UK healthcare providers and was made possible by educational funding provided by Napp Pharmaceuticals Ltd.

Stay informed with Medicine Matters

Get the latest developments in diabetes delivered straight to your inbox

Image Credits